drugset / Trial / NCT05230381

Intravenous Tranexamic Acid Reducing Intraoperative Blood Loss in Huge Meningiomas Resection

NCT05230381

Unknown 228 enrolled Beijing Tiantan Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Intra-operative blood loss of huge meningioma resection patients on average was over 1000ml. Intra-operative massive hemorrhage was associated with longer hospital of stay, higher expense, and higher mortality. Previous studies indicated intra-operative tranexamic acid infusion would decrease blood loss for cardiac, trauma and obstetric procedures. However, limited researches focusing on the effect of tranexamic acid in neurosurgery population, with heterogenous pathologies. The purpose of this study was to investigate the effect of tranexamic acid on intra-operative blood loss in patients undergoing huge meningioma resection.

Timeline

Start
2022-06-15
Primary completion
2024-12-30
Completion
2025-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 5 mg/kg Intravenous
Comparator Tranexamic Acid Small molecule 20 mg/kg Intravenous

Indications